Cash & equivalents increased 26.9%
Cash & equivalents changed +26.9% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +26.9% from the comparable as-filed period.
Debt changed +22.5% from the comparable as-filed period.
Net income changed -43150.0% from the comparable as-filed period.
Operating income changed -347.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed -804 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Research & development changed -29.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Stock-based compensation changed -24.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross margin changed +155 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross profit changed +10.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Revenue changed +8.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.